Reads to me that the drug indiscriminately attempts to shut down the inflammatory response not work with it like remestemcel?
But it's hard to tell with so little information?
Seems to me to years behind MSB as doesn't appear to have data from a safety trial?
Let alone if it works?
Manufacturing? Big step this to work out than get process and facility approved from authorities!
Shutting of inflammation response completely a good thing?
To many questions to know!
But seems years behind to me! Let alone wisdom of it!
Cell Therapy News/Articles, page-3218
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.005(0.39%) |
Mkt cap ! $1.467B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $1.653M | 1.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16781 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 9777 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |